Nodality, Inc. Names David R. Parkinson, MD as Its CEO
Published: Sep 24, 2007
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nodality, Inc., an emerging diagnostics company, today announced the appointment of David R. Parkinson, M.D., the former senior medical officer at Biogen Idec, as its first president and chief executive officer. The appointment is effective September 24, 2007. Nodality, Inc. is a privately held company funded by Kleiner Perkins Caufield & Byers (KPCB) and TPG Biotechnology.